Jacksonville Transportation Authority’s (JTA) facilities are now equipped with RGF® Environmental Group, Inc.’s, air treatment solutions.
“The Jacksonville Transportation Authority is committed to the safety of our customers and employees during this public health emergency and beyond,” said JTA Chief Executive Officer Nathaniel P. Ford Sr. “The installation of RGF’s equipment in our indoor spaces is an example of our commitment to providing a safe and welcoming environment for everyone to experience.”
The JTA’s 29 buildings represent more than 203,000-square feet protected by RGF air treatment solutions with a proven efficacy of greater than 99 percent for neutralizing the SARS-CoV-2 virus within indoor spaces.
“RGF is working with building owners across the United States to provide safe environments for employees,” said Tony Julian, vice president of commercial products, RGF® Environmental Group, Inc. “Multi-modal transportation hubs, such as the Jacksonville Regional Transportation Center, are critical links to get Americans safety to and from their places of work.”
“Within a service and maintenance contract with JTA, Weather Engineers, Inc. provided engineering and installation services for RGF’s air treatment solutions,” said Dan Griffin, president of Weather Engineers, Inc. “The Indoor Air Quality enhancement project includes the new Jacksonville Regional Transportation Center at LaVilla which serves as the JTA’s main bus transfer facility, regional mobility hub and the JTA’s administrative offices.”
For the project, the JTA chose RGF’s REME HALO®, Package PHI Units, Mini Split PHI, BLU QR® and PTAC PHI units.
RGF® equipment is installed in every HVAC unit and in every building that JTA occupies. When integrated into HVAC units, the RGF® equipment inactivates SARS-CoV-2 by more than 99.9 percent as demonstrated in a third-party study, according to the company.
The independent third-party study focused on the inactivation of SARS-CoV-2 using RGF’s REME HALO® product with PHI-Cell® technology. The study demonstrated efficacy rates greater than 99.9 percent in aerosolized reduction against the SARS-CoV-2 virus, commonly known as the coronavirus 2019 or COVID-19. The testing, performed at the Innovative Bioanalysis Laboratories in Cypress, Calif., looked at neutralizing the virus within the occupied space in the air and on surfaces.
